CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 1 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $4,240 | +94.2% | 100 | 0.0% | 0.00% | – |
| Q3 2023 | $2,183 | -31.3% | 100 | 0.0% | 0.00% | – |
| Q2 2023 | $3,179 | +30.3% | 100 | 0.0% | 0.00% | – |
| Q1 2023 | $2,439 | -22.7% | 100 | 0.0% | 0.00% | – |
| Q4 2022 | $3,154 | +11.6% | 100 | 0.0% | 0.00% | – |
| Q3 2022 | $2,826 | +6.9% | 100 | 0.0% | 0.00% | – |
| Q2 2022 | $2,644 | -24.5% | 100 | 0.0% | 0.00% | – |
| Q1 2022 | $3,501 | +8.0% | 100 | 0.0% | 0.00% | – |
| Q4 2021 | $3,242 | +9.9% | 100 | 0.0% | 0.00% | – |
| Q3 2021 | $2,950 | +15.1% | 100 | 0.0% | 0.00% | – |
| Q2 2021 | $2,562 | +86.6% | 100 | 0.0% | 0.00% | – |
| Q1 2021 | $1,373 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anchor Investment Management, LLC | 100 | $4,240 | 0.00% |